In an Extraordinary Year, Vertex Continues Its Unwavering Commitment to Corporate Responsibility; Announces 2021 CR Report
Apr 11, 2022 9:30 AM ET
2021 was an important year for Vertex and one that positioned the company well for the future as they continued to discover, develop and commercialize transformative medicines for people with serious diseases while demonstrating an unwavering commitment to corporate responsibility.
From increasing access to its cystic fibrosis medicines for thousands more patients, to continuing to integrate sustainability best practices into its operations and supporting education, innovation and health, Vertex’s 2021 achievements are the result of its employees, patients and communities working together.
Contact:
Sarah D’Souza, 857-329-8495
